Search

everythinglearnresearchcommunity

for

Search:↓

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Xeno-free three-dimensional stem cell masses are safe and effective for improving blood flow and tissue repair in limb ischemia.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Innovative methods are reducing animal testing and improving biomedical research.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Active oxygen scavengers can reverse the suppression of hair cell growth caused by androgens.

Different substances affect hair and skin cell growth in various ways.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Stress hormones and autoimmune reactions can cause hair loss.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

New therapies are being developed that target integrin pathways to treat various diseases.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Bone-forming cells grow well in 3D polymer scaffolds with 35 µm pores.

The review suggests that a special cell-derived treatment shows promise for various skin conditions and hair growth but needs more research for confirmation.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Hair follicle-derived extracellular vesicles may help heal chronic wounds as effectively as those from adipose tissue.

Perilla frutescens, an East Asian plant, contains 400 bioactive compounds that have various health benefits, including anti-inflammatory, antidepressant, and anticancer effects, and can treat conditions like diabetes, skin allergies, and neurological disorders.